Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 3-4, 2013-08 ,pp. : 229-241

Karger

Access to resources Recommend Favorite

A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of Administration

By  

Digestion, Vol. 84, Iss. 4, 2011-09 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study

By Petersenn Stephan   Farrall Andrew   Block Christophe   Melmed Shlomo   Schopohl Jochen   Caron Philippe   Cuneo Ross   Kleinberg David   Colao Annamaria   Ruffin Matthieu   Hermosillo Reséndiz Karina   Hughes Gareth   Hu Ke   Barkan Ariel  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 132-140

Springer Publishing Company

Access to resources Recommend Favorite

A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

By  

European Neurology, Vol. 44, Iss. 4, 2000-11 ,pp. : 236-241

Karger

Access to resources Recommend Favorite

Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study

By Petersenn Stephan   Farrall Andrew   Block Christophe   Melmed Shlomo   Schopohl Jochen   Caron Philippe   Cuneo Ross   Kleinberg David   Colao Annamaria   Ruffin Matthieu   Hermosillo Reséndiz Karina   Hughes Gareth   Hu Ke   Barkan Ariel  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 141-141

Springer Publishing Company

Access to resources Recommend Favorite